Neuronal nicotinic acetylcholine receptors serve as sensitive targets that mediate β-amyloid neurotoxicity

被引:20
作者
Liu, Qiang [1 ]
Wu, Jie [1 ]
机构
[1] St Josephs Hosp, Barrow Neurol Inst, Div Neurol, Phoenix, AZ 85013 USA
关键词
nicotinic acetylcholine receptor; beta-amyloid peptides; neurodegeneration; Alzheimer's disease;
D O I
10.1111/j.1745-7254.2006.00430.x
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Alzheimer's disease (AD) is the most common form of brain dementia characterized by the accumulation of beta-amyloid peptides (A beta) and loss of forebrain cholinergic neurons. A beta accumulation and aggregation are thought to contribute to cholinergic neuronal degeneration, in turn causing learning and memory deficits, but the specific targets that mediate A beta neurotoxicity remain elusive. Recently, accumulating lines of evidence have demonstrated that A beta directly modulates the function of neuronal nicotinic acetylcholine receptors (nAChRs), which leads to the new hypothesis that neuronal nAChRs may serve as important targets that mediate A beta neurotoxicity. In this review, we summarize current studies performed in our laboratory and in others to address the question of how A beta modulates neuronal nAChRs, especially nAChR subunit function.
引用
收藏
页码:1277 / 1286
页数:10
相关论文
共 115 条
  • [1] Albuquerque EX, 1997, J PHARMACOL EXP THER, V280, P1117
  • [2] α7 nicotinic acetylcholine receptors and modulation of gabaergic synaptic transmission in the hippocampus
    Alkondon, M
    Braga, MFM
    Pereira, EFR
    Maelicke, A
    Albuquerque, EX
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 393 (1-3) : 59 - 67
  • [3] Alkondon M, 1997, J PHARMACOL EXP THER, V283, P1396
  • [4] Alkondon M, 1996, J PHARMACOL EXP THER, V279, P1491
  • [5] ALKONDON M, 1993, J PHARMACOL EXP THER, V265, P1455
  • [6] Protofibrillar islet amyloid polypeptide permeabilizes synthetic vesicles by a pore-like mechanism that may be relevant to type II diabetes
    Anguiano, M
    Nowak, RJ
    Lansbury, PT
    [J]. BIOCHEMISTRY, 2002, 41 (38) : 11338 - 11343
  • [7] ARISPE N, 1994, ANN NY ACAD SCI, V747, P256
  • [8] COMPARATIVE ALTERATIONS OF NICOTINIC AND MUSCARINIC BINDING-SITES IN ALZHEIMERS AND PARKINSONS DISEASES
    AUBERT, I
    ARAUJO, DM
    CECYRE, D
    ROBITAILLE, Y
    GAUTHIER, S
    QUIRION, R
    [J]. JOURNAL OF NEUROCHEMISTRY, 1992, 58 (02) : 529 - 541
  • [9] Alzheimer's disease and the basal forebrain cholinergic system:: relations to β-amyloid peptides, cognition, and treatment strategies
    Auld, DS
    Kornecook, TJ
    Bastianetto, S
    Quirion, R
    [J]. PROGRESS IN NEUROBIOLOGY, 2002, 68 (03) : 209 - 245
  • [10] Avdulov NA, 1997, J NEUROCHEM, V68, P2086